We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDY icon
2526
Dr. Reddy's Laboratories
RDY
$9.8B
$795K ﹤0.01%
+71,340
New +$809K
NIU
2527
Niu Technologies
NIU
$200M
$792K ﹤0.01%
81,865
-1,534
-2% -$19.3K
ROCC
2528
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$790K ﹤0.01%
+22,888
New +$748K
VHC icon
2529
VirnetX Holding Corp
VHC
$53.8M
$786K ﹤0.01%
24,103
+1,191
+5% +$48.7K
BBAX icon
2530
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.66B
$785K ﹤0.01%
+14,113
New +$756K
HWKZ.WS
2531
CALL
DELISTED
Hawks Acquisition Corp Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
HWKZ.WS
$784K ﹤0.01%
80,484
IGTA
2532
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
$783K ﹤0.01%
+79,547
New +$780K
ESS icon
2533
Essex Property Trust
ESS
$19.1B
$781K ﹤0.01%
+2,260
New +$755K
PCAR icon
2534
PACCAR
PCAR
$70.5B
$781K ﹤0.01%
13,293
-45,252
-77% -$2.76M
VRSK icon
2535
Verisk Analytics
VRSK
$27.9B
$781K ﹤0.01%
3,641
-161,827
-98% -$31.9M
WTER
2536
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$780K ﹤0.01%
56,570
-35,430
-39% -$524K
CIR
2537
DELISTED
CIRCOR International, Inc
CIR
$779K ﹤0.01%
+29,149
New +$773K
PEBO icon
2538
Peoples Bancorp
PEBO
$1.51B
$778K ﹤0.01%
24,834
+22,996
+1,251% +$746K
DOMA.WS
2539
CALL
DELISTED
Doma Holdings, Inc. Warrants, Every 25 warrants will be exercisable for one share of Common Stock at an exercise price of $287.50 per share of Common Stock
DOMA.WS
$778K ﹤0.01%
359,713
-36,200
-9% -$21K
XNET
2540
Xunlei
XNET
$333M
$773K ﹤0.01%
439,216
-54,481
-11% -$93.9K
PRLD icon
2541
Prelude Therapeutics
PRLD
$375M
$772K ﹤0.01%
111,777
-156,241
-58% -$1.43M
LPCN icon
2542
Lipocine
LPCN
$17.1M
$771K ﹤0.01%
+33,098
New +$693K
TPH
2543
DELISTED
Tri Pointe Homes
TPH
$771K ﹤0.01%
38,396
-133,731
-78% -$3.11M
EFC
2544
Ellington Financial
EFC
$1.69B
$770K ﹤0.01%
43,404
-214,061
-83% -$3.77M
GMDA
2545
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$770K ﹤0.01%
185,700
+78,851
+74% +$264K
AVA icon
2546
Avista
AVA
$3.43B
$766K ﹤0.01%
+16,963
New +$747K
APTS
2547
DELISTED
Preferred Apartment Communities, Inc.
APTS
$762K ﹤0.01%
+30,546
New +$662K
ITW icon
2548
Illinois Tool Works
ITW
$84.1B
$761K ﹤0.01%
3,636
-17,608
-83% -$3.94M
UBX
2549
DELISTED
Unity Biotechnology
UBX
$759K ﹤0.01%
67,787
-21,411
-24% -$240K
ENIA
2550
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$758K ﹤0.01%
+127,175
New +$737K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.